These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12585754)

  • 21. The development of new allocation policy for deceased donor kidneys.
    Shapiro ME
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):512-5. PubMed ID: 18089963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Maximally reduced suffering or care based on needs?].
    Carlsson P; Liss PE
    Lakartidningen; 2008 May 7-13; 105(19):1412-3; discussion 1413-4. PubMed ID: 18574985
    [No Abstract]   [Full Text] [Related]  

  • 23. Seeking value in working with pharmacy benefit managers.
    Vogenberg FR; Sica JM
    Benefits Q; 2003; 19(1):7-12. PubMed ID: 12608113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug benefit decisions among older adults: a policy-capturing analysis.
    Cline RR; Gupta K
    Med Decis Making; 2006; 26(3):273-81. PubMed ID: 16751326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of PBMs in implementing the Medicare prescription drug benefit.
    Atlas RF
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-504-15. PubMed ID: 15513957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women, men and public health-how the choice of normative theory affects resource allocation.
    Månsdotter A; Lindholm L; Ohman A
    Health Policy; 2004 Sep; 69(3):351-64. PubMed ID: 15276314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription drug benefits: promising solutions.
    Goff VV
    Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug insurance instability and its correlates: results from the 2000 Medical Expenditure Panel Survey.
    Gupta K; Cline RR; Schondelmeyer SW
    Res Social Adm Pharm; 2006 Jun; 2(2):232-53. PubMed ID: 17138510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cluster analysis of state Medicaid prescription drug benefit programs based on potential determinants of per capita drug expenditure.
    Roy S; Madhavan SS
    Res Social Adm Pharm; 2009 Mar; 5(1):51-62. PubMed ID: 19285289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to make money? You are a county council's chief physician].
    Andrén-Sandberg A
    Lakartidningen; 2003 Sep; 100(39):3060-3. PubMed ID: 14560672
    [No Abstract]   [Full Text] [Related]  

  • 32. Debate rages over pharmaceutical coverage for seniors.
    Benjamin GC
    Physician Exec; 2001; 27(5):86-7. PubMed ID: 12881913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance.
    Yang BM; Bae EY; Kim J
    Health Aff (Millwood); 2008; 27(1):179-87. PubMed ID: 18180493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicare program; Medicare prescription drug benefit; interpretation. Final rule; interpretation.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Mar; 70(53):13397-400. PubMed ID: 15786588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada.
    Rosenberg-Yunger ZR; Daar AS; Singer PA; Martin DK
    Health Policy; 2008 Sep; 87(3):359-68. PubMed ID: 18358556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Health economics play more and more important role in health care prioritization. Better utilization of the meager health care resources is the goal].
    Carlsson P; Anders A; Eliasson M
    Lakartidningen; 2006 Nov 15-21; 103(46):3617-20, 3622-3. PubMed ID: 17153871
    [No Abstract]   [Full Text] [Related]  

  • 39. The new Medicare prescription drug benefit: important issues for physician practices.
    Falk R; Stranne S
    J Med Pract Manage; 2005; 21(3):133-7. PubMed ID: 16471382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.